Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
Sir Michael Wilshaw has renewed his demand for chains of academies to be allowed to be inspected after a report focused on Academies Enterprise Trust revealed that over half of its academies required improvement.
As the number of reports expressing concern about the larger chains’ performance increases, the clamour for effective monitoring and support for them will become louder.
The current situation raises interesting questions about whether the gap left by local authorities in monitoring and supporting schools has been effectively filled in connection with academies, particularly in connection with academy chains - see our report.
The potential 'middle tier' in this sense may be the newly appointed Regional School Commissioners (RSCs). It is unclear from the proposed scope of their work whether their current role includes monitoring of the larger groups but it would be intriguing to see over the coming months whether RSCs will become involved in monitoring the performance of academy groups.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Select which mailings you would like to receive from us.
Sign up